PortfoliosLab logoPortfoliosLab logo
AMX vs. VRTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMX vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMX achieves a 25.06% return, which is significantly higher than VRTX's 3.32% return. Over the past 10 years, AMX has underperformed VRTX with an annualized return of 11.26%, while VRTX has yielded a comparatively higher 19.05% annualized return.


AMX

1D
-0.88%
1M
-1.11%
YTD
25.06%
6M
24.16%
1Y
56.39%
3Y*
9.44%
5Y*
14.40%
10Y*
11.26%

VRTX

1D
0.35%
1M
7.80%
YTD
3.32%
6M
2.01%
1Y
5.61%
3Y*
10.52%
5Y*
19.53%
10Y*
19.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMX vs. VRTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMX
América Móvil, S.A.B. de C.V.
25.06%48.56%-20.36%4.60%-9.82%48.68%-6.62%15.01%-15.29%39.13%
VRTX
Vertex Pharmaceuticals Incorporated
3.32%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%

Correlation

The correlation between AMX and VRTX is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Feb 8, 2001

0.25

The correlation between AMX and VRTX shifts across timeframes, from 0.06 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMX:

$78.13B

VRTX:

$120.06B

EPS

AMX:

MX$29.05

VRTX:

$16.87

PE Ratio

AMX:

15.46

VRTX:

27.77

PEG Ratio

AMX:

0.31

VRTX:

2.31

PS Ratio

AMX:

1.43

VRTX:

9.83

PB Ratio

AMX:

3.11

VRTX:

4.53

Total Revenue (TTM)

AMX:

MX$944.51B

VRTX:

$12.26B

Gross Profit (TTM)

AMX:

MX$453.55B

VRTX:

$10.57B

EBITDA (TTM)

AMX:

MX$383.46B

VRTX:

$5.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMX vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMX
AMX Risk / Return Rank: 8888
Overall Rank
AMX Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
AMX Sortino Ratio Rank: 9090
Sortino Ratio Rank
AMX Omega Ratio Rank: 8888
Omega Ratio Rank
AMX Calmar Ratio Rank: 8787
Calmar Ratio Rank
AMX Martin Ratio Rank: 8888
Martin Ratio Rank

VRTX
VRTX Risk / Return Rank: 4646
Overall Rank
VRTX Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 4242
Sortino Ratio Rank
VRTX Omega Ratio Rank: 4545
Omega Ratio Rank
VRTX Calmar Ratio Rank: 4949
Calmar Ratio Rank
VRTX Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMX vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMXVRTXDifference
Sharpe ratioReturn per unit of total volatility

+1.91

Sortino ratioReturn per unit of downside risk

+2.70

Omega ratioGain probability vs. loss probability

1.38

1.07

+0.31

Calmar ratioReturn relative to maximum drawdown

3.69

0.24

+3.45

Martin ratioReturn relative to average drawdown

9.81

0.50

+9.32

AMX vs. VRTX - Sharpe Ratio Comparison

The current AMX Sharpe Ratio is 2.07, which is higher than the VRTX Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of AMX and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMX vs. VRTX - Drawdown Comparison

The maximum AMX drawdown since its inception was -64.34%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for AMX and VRTX.


Loading charts...

Drawdown Indicators


AMXVRTXDifference

Max Drawdown

Largest peak-to-trough decline

-64.34%

-91.77%

+27.43%

Max Drawdown (1Y)

Largest decline over 1 year

-15.36%

-23.56%

+8.20%

Max Drawdown (3Y)

Largest decline over 3 years

-35.44%

-29.07%

-6.37%

Max Drawdown (5Y)

Largest decline over 5 years

-38.08%

-29.07%

-9.01%

Max Drawdown (10Y)

Largest decline over 10 years

-44.45%

-41.60%

-2.85%

Current Drawdown

Current decline from peak

-6.85%

-9.35%

+2.50%

Average Drawdown

Average peak-to-trough decline

-24.08%

-37.71%

+13.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.76%

11.35%

-5.59%

Volatility

AMX vs. VRTX - Volatility Comparison

América Móvil, S.A.B. de C.V. (AMX) has a higher volatility of 10.15% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.70%. This indicates that AMX's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMXVRTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.15%

7.70%

+2.45%

Volatility (6M)

Calculated over the trailing 6-month period

21.79%

21.02%

+0.77%

Volatility (1Y)

Calculated over the trailing 1-year period

27.36%

34.18%

-6.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.95%

28.56%

-2.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.97%

32.74%

-3.77%

Dividends

AMX vs. VRTX - Dividend Comparison

AMX's dividend yield for the trailing twelve months is around 2.14%, while VRTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMX
América Móvil, S.A.B. de C.V.
2.14%2.68%3.59%2.83%4.41%1.88%2.49%2.29%2.24%1.91%2.27%8.55%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

AMX vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between América Móvil, S.A.B. de C.V. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B250.00B20222023202420252026
236.84B
2.99B
(AMX) Total Revenue
(VRTX) Total Revenue
Please note, different currencies. AMX values in MXN, VRTX values in USD

AMX vs. VRTX - Profitability Comparison

The chart below illustrates the profitability comparison between América Móvil, S.A.B. de C.V. and Vertex Pharmaceuticals Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
62.6%
86.9%
Portfolio components
AMX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, América Móvil, S.A.B. de C.V. reported a gross profit of 148.31B and revenue of 236.84B. Therefore, the gross margin over that period was 62.6%.

VRTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.59B and revenue of 2.99B. Therefore, the gross margin over that period was 86.9%.

AMX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, América Móvil, S.A.B. de C.V. reported an operating income of 50.52B and revenue of 236.84B, resulting in an operating margin of 21.3%.

VRTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.14B and revenue of 2.99B, resulting in an operating margin of 38.1%.

AMX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, América Móvil, S.A.B. de C.V. reported a net income of 23.40B and revenue of 236.84B, resulting in a net margin of 9.9%.

VRTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.03B and revenue of 2.99B, resulting in a net margin of 34.5%.


Frequently Asked Questions


AMX and VRTX have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMX has higher volatility (10.15%) compared to VRTX (7.70%). In terms of maximum drawdown, AMX dropped -64.34% vs VRTX's -91.77%.

AMX currently has the higher Sharpe Ratio (2.07 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMX and VRTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer